A new Stanford blood test detects cancer and tissue damage by analyzing rare RNA fragments in the blood. Stanford Medicine ...

The treatment, which aimed to block production of a mutant protein, reduced the frequency of infant’s seizures, but did not ...

Creyon Bio, Inc. (Creyon) announced a global licensing and multi-target research collaboration with Eli Lilly and Company (Lilly) focused on the discovery, development, and commercialization of novel ...

Many diseases are caused by a missing or defective copy of a single gene. For decades, scientists have been working on gene ...

Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments ...

In 2023, tuberculosis (TB) killed about 1.25 million people worldwide, more than any other infectious disease on Earth — even though it is curable. Months- or even years-long regimens of potent ...

To help achieve more precise control of gene therapy, engineers have designed a new control circuit that can keep gene expression levels within a target range. The method could be used to deliver ...

An artificial intelligence (AI)-based model developed by UT Southwestern Medical Center researchers can accurately predict ...

Fred Hutch and MSK researchers showed that tumors driven by hiccups in RNA processing can't hid from the immune system. In ...

Letter, Bloomberg Distinguished Professor Jeff Coller discussed his research on the development of a new experimental protein ...